Resource Centre
Discover a wealth of knowledge and insights from the experts at StarFish Medical. Our Resource Centre offers product development tips, reviews of new and cutting-edge technologies, and in-depth articles on regulatory updates and compliance in medical device development.
-
Biological sciences medical device breakthroughs for this decade have a solid base to build upon. Here are our top five picks for the 2020's.
-
Dr. Katherine Elvira speaks about her work developing lab-on-a-chip (microfluidic) technologies to investigate how drugs enter human cells.
-
Developing a “lab-on-a-chip” (LOC) solution brings unique challenges and benefits. 6 tips for developing a “lab-on-a-chip” (LOC) solution.
-
The amount of total company funding to develop a Class II 510(k) cleared medical device is approximately $30 million. The development and engineering costs comprise approximately $2-5 million of this total. This estimate is built upon a meta-analysis of various references as well as our experiences in engaging with companies. Many factors influence these costs, including the need for clinical studies, regulatory pathway, and technology complexity. Refinement of these numbers requires a professional team to understand the technology, regulatory, and business opportunities.
-
Testing Medical Devices in a Biolab? Pre-planning is required for specialized tests, potentially dangerous microorganisms, tissues and biological fluids.
-
How to create accurate and functional 3D models from patient imaging data. Develop anatomically accurate prototypes for medical device design.
-
There are a lot of things to consider when creating a summative usability test. The first time can be overwhelming. What scenarios do I test? How do I identify a critical task? How many participants do I need? Do I need to test the training? In this eGuide I will help you avoid common mistakes, like using a formative test structure for a summative usability test. I will also provide some tricks and tips to help you get the most out of your test participants and testing.
-
Michael May, President and Chief Executive Officer of CCRM discusses the intersection of medical devices in Regenerative Medicine.
-
Chimeric antigen receptor T-cell (CAR-T) therapy is a rising shining star in Regenerative Medicine. Medical devices will be involved.